If Taken 1 Hour before Indinavir (IDV), Didanosine Does Not Affect IDV Exposure, despite Persistent Buffering Effects

Por Shelton, Mark J., Mei, Haijing, Hewitt, Ross G., Defrancesco, Robin
Publicado em 2001

Pharmacokinetic and Safety Evaluation of High-Dose Combinations of Fosamprenavir and Ritonavir

Por Shelton, Mark J., Wire, Mary Beth, Lou, Yu, Adamkiewicz, Brigette, Min, Sherene S.
Publicado em 2006

Pharmacokinetics of Ritonavir and Delavirdine in Human Immunodeficiency Virus-Infected Patients

Por Shelton, Mark J., Hewitt, Ross G., Adams, John, Della-Coletta, Andrew, Cox, Steven, Morse, Gene D.
Publicado em 2003

Use of a Repetitive DNA Probe To Type Clinical and Environmental Isolates of Aspergillus flavus from a Cluster of Cutaneous Infections in a Neonatal Intensive Care Unit

Por James, Michael J., Lasker, Brent A., McNeil, Michael M., Shelton, Mark, Warnock, David W., Reiss, Errol
Publicado em 2000

Zanamivir Pharmacokinetics and Pulmonary Penetration into Epithelial Lining Fluid following Intravenous or Oral Inhaled Administration to Healthy Adult Subjects

Por Shelton, Mark J., Lovern, Mark, Ng-Cashin, Judith, Jones, Lori, Gould, Elizabeth, Gauvin, Jennifer, Rodvold, Keith A.
Publicado em 2011

Relationship between Didanosine Exposure and Surrogate Marker Response in Human Immunodeficiency Virus-Infected Outpatients

Por Adams, John M., Shelton, Mark J., Hewitt, Ross G., Grasela, Thaddeus H., DeRemer, Mary, Morse, Gene D.
Publicado em 1998

Pharmacokinetic Interaction between Fosamprenavir-Ritonavir and Rifabutin in Healthy Subjects

Por Ford, Susan L., Chen, Ya-Chi, Lou, Yu, Borland, Julie, Min, Sherene S., Yuen, Geoffrey J., Shelton, Mark J.
Publicado em 2008

Ritonavir Increases Plasma Amprenavir (APV) Exposure to a Similar Extent when Coadministered with either Fosamprenavir or APV

Por Wire, Mary B., Baker, Katherine L., Jones, Lori S., Shelton, Mark J., Lou, Yu, Thomas, Greg J., Berrey, M. Michelle
Publicado em 2006

Plasma Amprenavir Pharmacokinetics and Tolerability following Administration of 1,400 Milligrams of Fosamprenavir Once Daily in Combination with either 100 or 200 Milligrams of Rit...

Por Ruane, Peter J., Luber, Andrew D., Wire, Mary Beth, Lou, Yu, Shelton, Mark J., Lancaster, C. Tracey, Pappa, Keith A.
Publicado em 2007

Fosamprenavir plus Ritonavir Increases Plasma Ketoconazole and Ritonavir Exposure, while Amprenavir Exposure Remains Unchanged

Por Wire, Mary B., Ballow, Charles H., Borland, Julie, Shelton, Mark J., Lou, Yu, Yuen, Geoffrey, Lin, Jiang, Lewis, Eric W.
Publicado em 2007

Zalcitabine Population Pharmacokinetics: Application of Radioimmunoassay

Por Adams, John M., Shelton, Mark J., Hewitt, Ross G., DeRemer, Mary, DiFrancesco, Robin, Grasela, Thaddeus H., Morse, Gene D.
Publicado em 1998

Interaction between Fosamprenavir, with and without Ritonavir, and Nevirapine in Human Immunodeficiency Virus-Infected Subjects

Por DeJesus, Edwin, Piliero, Peter J., Summers, Kim, Wire, Mary Beth, Stein, Daniel S., Masterman, Amanda, Lou, Yu, Min, Sherene S., Shelton, Mark J.
Publicado em 2006

Neurodevelopmental Outcomes Following Ganciclovir Therapy in Symptomatic Congenital Cytomegalovirus Infections Involving the Central Nervous System

Por Oliver, Sara E., Cloud, Gretchen A., Sánchez, Pablo J., Demmler, Gail J., Dankner, Wayne, Shelton, Mark, Jacobs, Richard F., Vaudry, Wendy, Pass, Robert F., Soong, Seng-jaw, Whitley, Richard J., Kimberlin, David W.
Publicado em 2009

Safety of Oseltamivir Compared With the Adamantanes in Children Less Than 12 Months of Age

Por Kimberlin, David W., Shalabi, Marwan, Abzug, Mark J., Lang, David, Jacobs, Richard F., Storch, Gregory, Bradley, John S., Wade, Kelly C, Ramilo, Octavio, Romero, José R., Shelton, Mark, Leach, Charles, Guzman-Cottrill, Judith, Robinson, Joan, Abughali, Nazha, Englund, Janet, Griffin, Jill, Jester, Penny, Cloud, Gretchen A., Whitley, Richard J.
Publicado em 2010

A Randomized, Double-Blind, Placebo-Controlled Trial of Pleconaril for the Treatment of Neonates With Enterovirus Sepsis

Por Abzug, Mark J., Michaels, Marian G., Wald, Ellen, Jacobs, Richard F., Romero, José R., Sánchez, Pablo J., Wilson, Gregory, Krogstad, Paul, Storch, Gregory A., Lawrence, Robert, Shelton, Mark, Palmer, April, Robinson, Joan, Dennehy, Penelope, Sood, Sunil K., Cloud, Gretchen, Jester, Penelope, Acosta, Edward P., Whitley, Richard, Kimberlin, David
Publicado no J Pediatric Infect Dis Soc (2016)

Oral Acyclovir Suppression and Neurodevelopment after Neonatal Herpes

Por Kimberlin, David W., Whitley, Richard J., Wan, Wen, Powell, Dwight A., Storch, Gregory, Ahmed, Amina, Palmer, April, Sánchez, Pablo J., Jacobs, Richard F., Bradley, John S., Robinson, Joan L., Shelton, Mark, Dennehy, Penelope H., Leach, Charles, Rathore, Mobeen, Abughali, Nazha, Wright, Peter, Frenkel, Lisa M., Brady, Rebecca C., Van Dyke, Russell, Weiner, Leonard B., Guzman-Cottrill, Judith, McCarthy, Carol A., Griffin, Jill, Jester, Penelope, Parker, Misty, Lakeman, Fred D., Kuo, Huichien, Lee, Choo Hyung, Cloud, Gretchen A.
Publicado em 2011